Schering's Proventil
Executive Summary
Switchovers to Repetabs formula of beta-agonist bronchodilator accounted for one-third of all Proventil tablet sales in 1988, not one-third of the asthma drug's total volume, as reported in the March 20 issue of "The Pink Sheet" (T&G-6). Repetabs sales represent about 6% of total $ 100 mil. Proventil sales. The product is a b.i.d. formulation. Proventil inhaler volume is roughly $ 59 mil., followed in order by $ 19 mil. for solution form, $ 13 mil. for tablets and roughly $ 3 mil. for Proventil syrup.